The purpose of this report is to present a case of myeloid sarcoma of the gingiva with myelodysplastic syndrome.
Introduction
Myeloid sarcoma (previously known as granulocytic sarcoma or chloroma) is an uncommon extramedullary tumor composed of dense aggregates of immature myeloid precursor cells. [1] Infiltrations of any site of the body by myeloid precursor cells in leukemic patients are not classified as myeloid sarcoma unless they present tumor masses in which the tissue architecture effaced. [2] Myeloid sarcoma was reported in only 3% to 9% of patients with myeloid leukemia, and 60% of patients with myeloid sarcoma are <15 years of age. [3] Although myeloid sarcoma can affect almost every site of the body, it has been reported more often in the skin, bone, and lymph node. [4, 5] The involvement of multiple myeloid sarcoma sites is found in <10% of cases. [4, 5] Myeloid sarcoma may develop de novo or concurrently with acute myeloid leukemia, myeloproliferative neoplasm, or myelodysplastic syndrome.
The purpose of this report is to present a case of myeloid sarcoma of the gingiva with myelodysplastic syndrome. Intraoral occurrence of myeloid sarcoma is extremely rare. [6] Although several myeoloid sarcoma of the oral cavity were reported previously, [1, [6] [7] [8] [9] [10] [11] [12] [13] [14] 2-site involvement, including gingiva and skin, may be a rare case.
Ethics, consent, and permissions
This study was reviewed and approved by the Institutional Review Board of Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea (KC14ZISE0338).
Case presentation
The 52-year-old male patient was previously diagnosed with myelodysplastic syndrome at another hospital. A hematologic test showed that the patient was suspected of conversion to acute myeloid leukemia. Closer examination showed that the patient was suspected of refractory anemia with excess blasts-1 or chronic myelomonocytic leukemia. Multiple skin-colored or bluish masses were presented on the trunk for 10 days. Skin biopsy and histologic sections showed perivascular and diffuse infiltration of atypical mononuclear cells in the mid and deep dermis ( Fig. 1A and B) . On immunohistochemical staining, the tumor cells were positive for CD68 (Fig. 1C ) and myeloperoxidase (Fig. 1D) . Histopathological findings were compatible with leukemia cutis. The patient was referred from the Department of Hematology to the Department of Periodontics for the biopsy of the lesion to evaluate the leukemic infiltration after visiting the Department of Oral and Maxillofacial Surgery. The patient's (Fig. 2A) . The deepest probing depth was 12 mm at the maxillary left second premolar and the maxillary left first molar interdental area. In periapical radiograph, the widening of periodontal ligament space was observed at the maxillary left second premolar (Fig. 2B) . There was consultation with the Department of Hematology for the possibilities and considerations of the flap operation and an extraction was made. Fullthickness flaps were elevated and inflamed and neoplastic soft tissues were removed from lesion ( Fig. 2C and D) . The samples were sent to the Department of Pathology for histopathologic analysis. Hematoxylin-eosin-stained sections revealed mass formation with atypical mononuclear cells beneath the oral epithelium ( Fig. 3A and B) . The tumor cells were positive for leukocyte common antigen CD45RB (Fig. 3C ) and myeloperoxidase (Fig. 3D ). In addition, some scattered cells were positive for CD34 and CD117 ( Fig. 3E and F) . The histopathological findings were compatible with myeloid leukemic infiltration of myeloid sarcoma. Uneventful healing was observed at 2-week follow-up ( Fig. 4A and B) . At the 4-week follow-up, relapse of the lesions with the hyperplastic and neoplastic tissue was noted (Fig. 4C) . Periapical radiograph showed bone loss at the interdental area between the maxillary left second premolar and the maxillary left first molar (Fig. 4D) . Extraction of the maxillary left second premolar was planned, but the patient did not visit at the next follow-up.
Discussion
Myeloid sarcoma may occur under 3 clinical settings: (1) it may precede or coincide with acute myeloid leukemia; (2) it may occur in patients with myelodysplastic syndromes or myeloproliferative neoplasm; (3) it may have initial manifestation of relapse of acute myeloid leukemia. [15] Myelodysplastic syndrome is the group of clonal hematopoietic stem cell diseases characterized by cytopenia, dysplasia in 1 or more of the major myeloid cell lines, ineffective hematopoiesis, and increased risk of development of acute myeloid leukemia. [16] In this report, therefore, the patient had the possibility of acute myeloid leukemia because of the myeloid sarcoma at 2 sites and increased risk of secondary acute myeloid leukemia in myelodysplastic syndrome patients. A previous study reported that acute myeloid leukemia occurs after 1 to 25 months in most cases of myeloid sarcoma. [17] In this report, rapid growth of tumor mass was observed 4 weeks after surgery. Several factors can be considered as the cause of relapse. Myeloid sarcoma has an invasive and aggressive character and the myeloid sarcoma-derived cell line has the type IV collagenase (matrix metalloproteinase-2 [MMP-2]). [18] Type IV collagenase has been reported to be related to poor prognosis for cancer. [19] Furthermore, myeloid sarcoma cells are the only cell line among several leukemic cell lines to bind both bone marrow stromal layers and dermal fibroblast. [20] The patient was under schedule for intensive chemotherapy and radiotherapy after the confirmation of the biopsy. The biopsy results in the Department of Dermatology and the Department of Periodontology may provide the rationale for a further treatment regimen for myeloid sarcoma, but open flap debridement performed for the biopsy may have increased the tumor growth. [21] Although there is no consensus about the treatment of myeloid sarcoma, the current recommended treatment regimen in patients presenting with isolated myeloid sarcoma or myeloid sarcoma presenting concomitantly with acute myeloid leukemia is conventional acute myeloid leukemia-type chemotherapy. [22] In conclusion, myeloid sarcoma should be a diagnosis option for gingival growth because it can involve intraoral lesion. In this report, a biopsy was performed due to referral considering the patient's medical history. Although myeloid sarcoma in the oral cavity is extremely rare, a small biopsy and consultation with a hematologist may be beneficial for patients and may provide a differential diagnosis.
